Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. The company operates through Consumer Health, Pharma, and Medical segments. It offers body and skin products; and natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce brand names. The company also provides medical devices, and diagnostic laboratory equipment and consumables for operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, research and science institutes, etc.; generic pharmaceutical products, antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives; and products for the nervous system, cardiovascular system, dermatological products, and antimalarials, as well as other therapeutic products under the Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group brands. In addition, it exports its products. The company serves pharmacies, retailers, beauticians, and doctors. Ascendis Health Limited was incorporated in 2008 and is based in Johannesburg, South Africa.
Ascendis Health Dividend Announcement
• Ascendis Health announced a semi annually dividend of R11.00 per ordinary share which will be made payable on 2017-05-15. Ex dividend date: 2017-05-10
• Ascendis Health's trailing twelve-month (TTM) dividend yield is -%
Ascendis Health Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2017-05-10 | R11.00 | semi annually | 2017-05-15 |
2016-11-30 | R12.00 | semi annually | |
2016-05-09 | R9.38 | semi annually | |
2015-11-30 | R10.86 | semi annually | |
2015-05-11 | R7.90 | semi annually | |
2014-12-08 | R14.81 | semi annually |
Ascendis Health Dividend per year
Ascendis Health Dividend growth
Ascendis Health Dividend Yield
Ascendis Health current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ascendis Health stock? Use our calculator to estimate your expected dividend yield:
Ascendis Health Financial Ratios
Ascendis Health Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Ascendis Health stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.